Charlotte, NC, United States of America

Laura Schrum


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Laura Schrum: Innovator in Hepatic Treatments

Introduction

Laura Schrum is a notable inventor based in Charlotte, NC (US). She has made significant contributions to the field of medicine, particularly in the treatment of liver-related conditions. With a total of 3 patents to her name, her work focuses on innovative methods for addressing serious health issues.

Latest Patents

One of Laura's latest patents is titled "Methods of treating portal hypertension." This invention provides methods for treating or preventing portal hypertension by administering at least one Rev-erb modulating agent (REMA) to patients in need. The REMA can include compounds such as SR6452, SR9009, or SR9011. The administration of these agents aims to modulate Rev-erbα expression and inhibit hepatic stellate cell activation.

Another significant patent is "Methods of treating hepatic fibrosis and associated diseases by regulating Rev-ERB activity." This invention focuses on compositions and methods for the treatment and prevention of hepatic fibrosis. The methods involve regulating Rev-erbα expression and activity, which can help reduce the activation of hepatic stellate cells.

Career Highlights

Laura Schrum is affiliated with the Charlotte-Mecklenburg Hospital Authority, where she applies her expertise in medical research and innovation. Her work has been instrumental in developing new therapeutic approaches for liver diseases.

Collaborations

Laura collaborates with talented individuals such as Ting Li and Ashley M Lakner, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Laura Schrum's contributions to the field of hepatic treatments through her patents demonstrate her commitment to advancing medical science. Her innovative approaches have the potential to significantly impact the treatment of liver-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…